Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...
Walk MS is coming to Soldier Field April 27. Help fight multiple sclerosis. Register now for Walk MS at Soldier Field on ...
Wright, from Bolton, was diagnosed with a life-changing condition 11 years after she first started experiencing episodes in ...
No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...
Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of MS ...
Oral ingestion of marijuana is emerging as a promising treatment for malaria, chronic pain and sleep disorders. THC and CBD have antimalarial, analgesic and sleep-promoting properties. Further ...
Explore more
The study aimed to determine whether treatment with high dose ocrelizumab would provide an additional benefit in slowing disability progression.
Running an entire marathon takes a lot of energy. Neuroscientist Carlos Matute knows this: he's run 18 of them. He wondered ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Number 5: Biosimilar natalizumab demonstrated comparable efficacy, safety, and immunogenicity to reference drug Tysabri in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results